Given that TRPV3 and TRPV4 were potential prognosis biomarkers, we developed a nomogram to predict the overall survival of ccRCC patients by fitting TRPV3/4 expression and TNM stage. The gene discussed is TRPV4; the disease is nonpapillary renal cell carcinoma.